US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Moleculin Biotech

0.5930

+0.00240.41%

Post-market: 0.5882-0.0048-0.81%19:35 EDT

Volume:294.18K

Turnover:173.86K

Market Cap:11.55M

PE:-0.06

High:0.6300

Open:0.5874

Low:0.5600

Close:0.5906

52wk High:15.75

52wk Low:0.1614

Shares:19.48M

Float Shares:17.03M

Volume Ratio:0.31

T/O Rate:1.73%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-9.7621

EPS(LYR):-28.4188

ROE:-1371.64%

ROA:-84.57%

PB:1.00

PE(LYR):-0.02

Loading ...

Overview Company News Filings

Moleculin Biotech Q1 FY26 net loss widens to $12.85 million; operating loss widens to $7.87 million

Buy Rating Reiterated on Moleculin Biotech as MIRACLE Trial Progress Supports Unchanged $10 Price Target

Nano-Cap Moleculin Biotech Approaches Key Leukemia Trial Data Unblinding

Moleculin Biotech expects first unblinding of MIRACLE trial data by June 30

BRIEF-Moleculin Biotech Inc - To Unblind Miracle Trial Data Before June 30, 2026 - SEC Filing

Moleculin Biotech Inc - Miracle Trial on Track to Complete Part a Recruitment in Q3 2026 - SEC Filing

THOMSON REUTERS

Moleculin nears MIRACLE trial unblinding for Annamycin in relapsed AML by June 30

Moleculin announces publication on cardiac safety profiloe of annamycin

Moleculin says Cleveland Clinic review finds no significant Annamycin cardiotoxicity in R/R AML

Moleculin Biotech issued liposomal Annamycin patent in Hong Kong

Moleculin Biotech secures Hong Kong patent for liposomal Annamycin reconstitution method

Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin

Moleculin says Annamycin extends survival 60% in pancreatic cancer preclinical models

Moleculin to present annamycin cardiac safety pooled analysis at ASCO 2026

Moleculin Biotech Stockholders Approve Warrant Share Issuance

Moleculin CEO highlights Annamycin’s non-cardiotoxic profile in CEO Corner interview

Moleculin Biotech management to meet with Maxim

Moleculin Biotech files to sell 6.37M shares of common stock for holders

Moleculin Biotech Price Target Maintained With a $22.00/Share by HC Wainwright & Co.

Moleculin enrolls 45th patient in MIRACLE AnnAraC trial for relapsed or refractory AML

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/MBRX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MBRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MBRX\",,,,,undefined,":{"symbol":"MBRX","market":"US","secType":"STK","nameCN":"Moleculin Biotech","latestPrice":0.593,"timestamp":1787342400000,"preClose":0.5906,"halted":0,"volume":294178,"hourTrading":{"tag":"盘后","latestPrice":0.5882,"preClose":0.593,"latestTime":"19:35 EDT","volume":6362,"amount":3694.8557,"timestamp":1787355323365,"change":-0.0048,"changeRate":-0.008094,"amplitude":0.022934},"delay":0,"changeRate":0.0040636640704367726,"floatShares":17031100,"shares":19477400,"eps":-9.762143,"marketStatus":"Not Yet Opened","change":0.0024,"latestTime":"08-21 16:00:00 EDT","open":0.5874,"high":0.63,"low":0.56,"amount":173856.94165474,"amplitude":0.118524,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.762143,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.5906,"preHourTrading":{"tag":"盘前","latestPrice":0.61,"preClose":0.5906,"latestTime":"09:28 EDT","volume":7529,"amount":4600.11532567,"timestamp":1787318930047,"change":0.0194,"changeRate":0.032848,"amplitude":0.066712},"postHourTrading":{"tag":"盘后","latestPrice":0.5882,"preClose":0.593,"latestTime":"19:35 EDT","volume":6362,"amount":3694.8557,"timestamp":1787355323365,"change":-0.0048,"changeRate":-0.008094,"amplitude":0.022934},"volumeRatio":0.305806538240416},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MBRX\",,,,,undefined,":{"symbol":"MBRX","floatShares":17031100,"roa":"-84.57%","roe":"-1371.64%","lyrEps":-28.418775,"volumeRatio":0.305806538240416,"shares":19477400,"dividePrice":0,"high":0.63,"amplitude":0.118524,"preClose":0.5906,"low":0.56,"week52Low":0.1614,"pbRate":"1.00","week52High":15.75,"institutionHeld":0,"latestPrice":0.593,"eps":-9.762143,"divideRate":0,"volume":294178,"delay":0,"ttmEps":-9.762143,"open":0.5874,"prevYearClose":3.31,"prevWeekClose":0.6122,"prevMonthClose":0.4,"prevQuarterClose":2.79,"fiveDayClose":0.6122,"twentyDayClose":2.12,"sixtyDayClose":2.73},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MBRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"MBRX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2026-05-14","symbol":"MBRX","fiscalQuarterEnding":"2026/03","expectedEps":-1.69,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-2.48},{"market":"US","date":"2026-03-19","symbol":"MBRX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-12-01","symbol":"MBRX","defaultRemindTime":1764599400000,"type":"split","dateTimestamp":1764565200000,"forFactor":25,"toFactor":1,"ratio":25},{"market":"US","date":"2025-11-13","symbol":"MBRX","fiscalQuarterEnding":"2025/09","expectedEps":-0.2,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MBRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MBRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1742961600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MBRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MBRX","date":"2026-08-21","current":-0.060745,"percent":0.717801,"low":-6.186345,"twenty":-2.07519,"median":-0.625788,"eighty":-0.295337,"high":-0.041817,"avg":-1.205808,"sd":1.338678,"marketCap":11503340},"quantilePoints":[{"date":"2021-08-27","current":-5.779094,"twenty":-6.688933,"median":-4.543555,"eighty":-3.027649,"marketCap":85085594},{"date":"2021-09-03","current":-6.147559,"twenty":-6.679696,"median":-4.546236,"eighty":-3.027649,"marketCap":90510515},{"date":"2021-09-10","current":-5.934237,"twenty":-6.668654,"median":-4.558623,"eighty":-3.027649,"marketCap":87369771},{"date":"2021-09-17","current":-6.031202,"twenty":-6.657551,"median":-4.57079,"eighty":-3.027649,"marketCap":88797382},{"date":"2021-09-24","current":-5.740308,"twenty":-6.647625,"median":-4.571143,"eighty":-3.028316,"marketCap":84514550},{"date":"2021-10-01","current":-5.430021,"twenty":-6.640295,"median":-4.595196,"eighty":-3.035197,"marketCap":79946196},{"date":"2021-10-08","current":-5.255484,"twenty":-6.638349,"median":-4.600065,"eighty":-3.045512,"marketCap":77376497},{"date":"2021-10-15","current":-5.255484,"twenty":-6.638349,"median":-4.61476,"eighty":-3.049661,"marketCap":77376497},{"date":"2021-10-22","current":-5.333056,"twenty":-6.633061,"median":-4.625073,"eighty":-3.049749,"marketCap":78518585},{"date":"2021-10-29","current":-5.119734,"twenty":-6.629535,"median":-4.655883,"eighty":-3.049749,"marketCap":75377842},{"date":"2021-11-05","current":-5.003376,"twenty":-6.603268,"median":-4.664895,"eighty":-3.049749,"marketCap":73664709},{"date":"2021-11-12","current":-4.493596,"twenty":-6.573592,"median":-4.662654,"eighty":-3.050384,"marketCap":70585407},{"date":"2021-11-19","current":-4.002393,"twenty":-6.559225,"median":-4.651352,"eighty":-3.050808,"marketCap":62869593},{"date":"2021-11-26","current":-3.91143,"twenty":-6.546414,"median":-4.625073,"eighty":-3.054203,"marketCap":61440739},{"date":"2021-12-03","current":-3.583961,"twenty":-6.533455,"median":-4.615601,"eighty":-3.064281,"marketCap":56296863},{"date":"2021-12-10","current":-4.238898,"twenty":-6.528828,"median":-4.603452,"eighty":-3.071796,"marketCap":66584615},{"date":"2021-12-17","current":-3.893237,"twenty":-6.521887,"median":-4.595196,"eighty":-3.071849,"marketCap":61154968},{"date":"2021-12-23","current":-3.693117,"twenty":-6.521887,"median":-4.590744,"eighty":-3.071849,"marketCap":58011488},{"date":"2021-12-31","current":-3.383842,"twenty":-6.521887,"median":-4.57079,"eighty":-3.071849,"marketCap":53153383},{"date":"2022-01-07","current":-3.311071,"twenty":-6.521887,"median":-4.564726,"eighty":-3.071849,"marketCap":52010300},{"date":"2022-01-14","current":-3.110951,"twenty":-6.517795,"median":-4.554887,"eighty":-3.071849,"marketCap":48866820},{"date":"2022-01-21","current":-2.783483,"twenty":-6.501428,"median":-4.544849,"eighty":-3.071849,"marketCap":43722944},{"date":"2022-01-28","current":-2.56517,"twenty":-6.493648,"median":-4.53412,"eighty":-3.056373,"marketCap":40293694},{"date":"2022-02-04","current":-2.710712,"twenty":-6.493648,"median":-4.525978,"eighty":-3.049749,"marketCap":42579861},{"date":"2022-02-11","current":-2.692519,"twenty":-6.478297,"median":-4.518786,"eighty":-3.049528,"marketCap":42294090},{"date":"2022-02-18","current":-2.474207,"twenty":-6.469401,"median":-4.493679,"eighty":-3.027649,"marketCap":38864839},{"date":"2022-02-25","current":-2.56517,"twenty":-6.464804,"median":-4.493596,"eighty":-3.027649,"marketCap":40293694},{"date":"2022-03-04","current":-2.401436,"twenty":-6.463655,"median":-4.474466,"eighty":-3.005507,"marketCap":37721756},{"date":"2022-03-11","current":-2.383243,"twenty":-6.463655,"median":-4.4674,"eighty":-3.002188,"marketCap":37435985},{"date":"2022-03-18","current":-2.692519,"twenty":-6.445671,"median":-4.424589,"eighty":-2.98345,"marketCap":42294090},{"date":"2022-03-25","current":-3.182563,"twenty":-6.438135,"median":-4.406707,"eighty":-2.977299,"marketCap":50583658},{"date":"2022-04-01","current":-3.272466,"twenty":-6.437375,"median":-4.399361,"eighty":-2.982508,"marketCap":52012575},{"date":"2022-04-08","current":-3.326408,"twenty":-6.405363,"median":-4.352398,"eighty":-2.982508,"marketCap":52869925},{"date":"2022-04-14","current":-3.596117,"twenty":-6.373321,"median":-4.313035,"eighty":-2.982508,"marketCap":57156676},{"date":"2022-04-22","current":-3.272466,"twenty":-6.347193,"median":-4.303161,"eighty":-2.982508,"marketCap":52012575},{"date":"2022-04-29","current":-2.858913,"twenty":-6.326447,"median":-4.268566,"eighty":-2.962474,"marketCap":45439557},{"date":"2022-05-06","current":-2.643146,"twenty":-6.277248,"median":-4.216616,"eighty":-2.953539,"marketCap":42010156},{"date":"2022-05-13","current":-1.934764,"twenty":-6.230731,"median":-4.173408,"eighty":-2.937568,"marketCap":35437139},{"date":"2022-05-20","current":-2.043985,"twenty":-6.230731,"median":-4.135144,"eighty":-2.89691,"marketCap":37437622},{"date":"2022-05-27","current":-2.356043,"twenty":-6.230731,"median":-4.100664,"eighty":-2.893757,"marketCap":43153290},{"date":"2022-06-03","current":-2.387249,"twenty":-6.216696,"median":-4.075277,"eighty":-2.876893,"marketCap":43724857},{"date":"2022-06-10","current":-2.34044,"twenty":-6.180904,"median":-4.058788,"eighty":-2.869844,"marketCap":42867507},{"date":"2022-06-17","current":-2.324837,"twenty":-6.133327,"median":-4.028164,"eighty":-2.855029,"marketCap":42581723},{"date":"2022-06-24","current":-2.278029,"twenty":-6.07916,"median":-4.012846,"eighty":-2.850547,"marketCap":41724373},{"date":"2022-07-01","current":-2.293632,"twenty":-6.019566,"median":-4.004608,"eighty":-2.849536,"marketCap":42010156},{"date":"2022-07-08","current":-2.636896,"twenty":-5.963394,"median":-4.004608,"eighty":-2.830815,"marketCap":48297391},{"date":"2022-07-15","current":-2.580258,"twenty":-5.940997,"median":-3.994243,"eighty":-2.819408,"marketCap":47259997},{"date":"2022-07-22","current":-2.948955,"twenty":-5.928624,"median":-3.973281,"eighty":-2.818063,"marketCap":54013058},{"date":"2022-07-29","current":-2.636896,"twenty":-5.876058,"median":-3.954705,"eighty":-2.806653,"marketCap":48297391},{"date":"2022-08-05","current":-2.652499,"twenty":-5.815779,"median":-3.940978,"eighty":-2.784554,"marketCap":48583174},{"date":"2022-08-12","current":-2.222786,"twenty":-5.766607,"median":-3.93784,"eighty":-2.76529,"marketCap":46342863},{"date":"2022-08-19","current":-2.305111,"twenty":-5.752805,"median":-3.91143,"eighty":-2.755163,"marketCap":48059266},{"date":"2022-08-26","current":-2.016972,"twenty":-5.720382,"median":-3.908675,"eighty":-2.745889,"marketCap":42051857},{"date":"2022-09-02","current":-1.962089,"twenty":-5.670493,"median":-3.900336,"eighty":-2.722463,"marketCap":40907589},{"date":"2022-09-09","current":-1.97581,"twenty":-5.640183,"median":-3.893237,"eighty":-2.714667,"marketCap":41193656},{"date":"2022-09-16","current":-1.797438,"twenty":-5.596232,"median":-3.876372,"eighty":-2.703491,"marketCap":37474784},{"date":"2022-09-23","current":-1.577904,"twenty":-5.526985,"median":-3.862833,"eighty":-2.695817,"marketCap":32897711},{"date":"2022-09-30","current":-1.454415,"twenty":-5.440626,"median":-3.841713,"eighty":-2.690922,"marketCap":30323108},{"date":"2022-10-07","current":-1.481857,"twenty":-5.411208,"median":-3.82533,"eighty":-2.674744,"marketCap":30895242},{"date":"2022-10-14","current":-1.37209,"twenty":-5.371842,"median":-3.811766,"eighty":-2.668102,"marketCap":28606706},{"date":"2022-10-21","current":-1.286334,"twenty":-5.344063,"median":-3.787827,"eighty":-2.661258,"marketCap":26818786},{"date":"2022-10-28","current":-1.357958,"twenty":-5.332588,"median":-3.784081,"eighty":-2.655824,"marketCap":28312056},{"date":"2022-11-04","current":-1.272339,"twenty":-5.288972,"median":-3.765888,"eighty":-2.64511,"marketCap":26526998},{"date":"2022-11-11","current":-1.073658,"twenty":-5.255484,"median":-3.750324,"eighty":-2.637068,"marketCap":26927334},{"date":"2022-11-18","current":-1.198533,"twenty":-5.23884,"median":-3.74716,"eighty":-2.636896,"marketCap":30059218},{"date":"2022-11-25","current":-1.472484,"twenty":-5.218697,"median":-3.714856,"eighty":-2.626865,"marketCap":36929896},{"date":"2022-12-02","current":-1.539373,"twenty":-5.197645,"median":-3.714856,"eighty":-2.621231,"marketCap":38607487},{"date":"2022-12-09","current":-1.518142,"twenty":-5.180271,"median":-3.693117,"eighty":-2.606679,"marketCap":38075009},{"date":"2022-12-16","current":-1.483899,"twenty":-5.158922,"median":-3.655815,"eighty":-2.601296,"marketCap":37216175},{"date":"2022-12-23","current":-1.381167,"twenty":-5.152911,"median":-3.65025,"eighty":-2.594501,"marketCap":34639670},{"date":"2022-12-30","current":-1.209948,"twenty":-5.124997,"median":-3.617947,"eighty":-2.587166,"marketCap":30345496},{"date":"2023-01-06","current":-1.381167,"twenty":-5.124997,"median":-3.585684,"eighty":-2.576597,"marketCap":34639670},{"date":"2023-01-13","current":-1.483899,"twenty":-5.124997,"median":-3.564996,"eighty":-2.56247,"marketCap":37216175},{"date":"2023-01-20","current":-1.461069,"twenty":-5.124997,"median":-3.553341,"eighty":-2.547444,"marketCap":36643618},{"date":"2023-01-27","current":-1.449655,"twenty":-5.121576,"median":-3.536555,"eighty":-2.539774,"marketCap":36357340},{"date":"2023-02-03","current":-1.403996,"twenty":-5.119734,"median":-3.521038,"eighty":-2.528785,"marketCap":35212227},{"date":"2023-02-10","current":-1.337563,"twenty":-5.119734,"median":-3.488735,"eighty":-2.510592,"marketCap":33546087},{"date":"2023-02-17","current":-1.472484,"twenty":-5.114394,"median":-3.483457,"eighty":-2.499636,"marketCap":36929896},{"date":"2023-02-24","current":-1.43824,"twenty":-5.090269,"median":-3.464544,"eighty":-2.493412,"marketCap":36071062},{"date":"2023-03-03","current":-1.381167,"twenty":-5.063718,"median":-3.450298,"eighty":-2.474314,"marketCap":34639670},{"date":"2023-03-10","current":-1.187119,"twenty":-5.04989,"median":-3.434291,"eighty":-2.461859,"marketCap":29772940},{"date":"2023-03-17","current":-1.118631,"twenty":-5.018906,"median":-3.424129,"eighty":-2.456738,"marketCap":28055270},{"date":"2023-03-24","current":-0.996179,"twenty":-5.001753,"median":-3.403043,"eighty":-2.435919,"marketCap":28914105},{"date":"2023-03-31","current":-0.946863,"twenty":-4.988177,"median":-3.395078,"eighty":-2.423552,"marketCap":27482713},{"date":"2023-04-06","current":-0.918154,"twenty":-4.988177,"median":-3.382543,"eighty":-2.408128,"marketCap":26649416},{"date":"2023-04-14","current":-0.946228,"twenty":-4.984446,"median":-3.365649,"eighty":-2.400207,"marketCap":27464280},{"date":"2023-04-20","current":-0.813785,"twenty":-4.984446,"median":-3.362043,"eighty":-2.387249,"marketCap":23620108},{"date":"2023-04-28","current":-0.699041,"twenty":-4.985249,"median":-3.342966,"eighty":-2.356895,"marketCap":20289672},{"date":"2023-05-05","current":-0.79344,"twenty":-4.985249,"median":-3.341543,"eighty":-2.34044,"marketCap":23029605},{"date":"2023-05-12","current":-0.7383,"twenty":-4.986857,"median":-3.328604,"eighty":-2.337487,"marketCap":22202901},{"date":"2023-05-19","current":-0.62569,"twenty":-4.98962,"median":-3.317536,"eighty":-2.324837,"marketCap":18816368},{"date":"2023-05-26","current":-0.615851,"twenty":-4.98962,"median":-3.311071,"eighty":-2.310472,"marketCap":18520485},{"date":"2023-06-02","current":-0.564538,"twenty":-4.98962,"median":-3.294916,"eighty":-2.306159,"marketCap":16977359},{"date":"2023-06-09","current":-0.610621,"twenty":-4.98962,"median":-3.278548,"eighty":-2.29487,"marketCap":18363205},{"date":"2023-06-16","current":-0.582202,"twenty":-4.992383,"median":-3.270745,"eighty":-2.291297,"marketCap":17508550},{"date":"2023-06-23","current":-0.591872,"twenty":-4.995145,"median":-3.259541,"eighty":-2.269684,"marketCap":17799370},{"date":"2023-06-30","current":-0.548552,"twenty":-4.997908,"median":-3.245815,"eighty":-2.262426,"marketCap":16496616},{"date":"2023-07-07","current":-0.564242,"twenty":-4.997908,"median":-3.2383,"eighty":-2.247347,"marketCap":16968456},{"date":"2023-07-14","current":-0.709201,"twenty":-4.997908,"median":-3.227787,"eighty":-2.217051,"marketCap":21327789},{"date":"2023-07-20","current":-0.654434,"twenty":-4.997908,"median":-3.216919,"eighty":-2.20387,"marketCap":19680798},{"date":"2023-07-28","current":-0.641409,"twenty":-5.000671,"median":-3.194941,"eighty":-2.168808,"marketCap":19289081},{"date":"2023-08-04","current":-0.611805,"twenty":-5.001212,"median":-3.177182,"eighty":-2.144839,"marketCap":18398816},{"date":"2023-08-11","current":-0.621673,"twenty":-5.001212,"median":-3.160125,"eighty":-2.07519,"marketCap":18695571},{"date":"2023-08-18","current":-0.586595,"twenty":-5.001212,"median":-3.142523,"eighty":-2.030693,"marketCap":17170815},{"date":"2023-08-25","current":-0.570403,"twenty":-5.001212,"median":-3.122596,"eighty":-2.016133,"marketCap":16696829},{"date":"2023-09-01","current":-0.570301,"twenty":-5.001212,"median":-3.104845,"eighty":-1.965194,"marketCap":16693848},{"date":"2023-09-08","current":-0.397683,"twenty":-5.001212,"median":-3.07346,"eighty":-1.948368,"marketCap":11640977},{"date":"2023-09-15","current":-0.399211,"twenty":-5.001212,"median":-3.065528,"eighty":-1.901704,"marketCap":11685693},{"date":"2023-09-22","current":-0.427726,"twenty":-5.001753,"median":-3.050808,"eighty":-1.79195,"marketCap":12520386},{"date":"2023-09-29","current":-0.430781,"twenty":-5.001753,"median":-3.049749,"eighty":-1.685173,"marketCap":12609817},{"date":"2023-10-06","current":-0.499013,"twenty":-5.001753,"median":-3.027649,"eighty":-1.609459,"marketCap":14607117},{"date":"2023-10-13","current":-0.412959,"twenty":-5.001753,"median":-3.027649,"eighty":-1.577904,"marketCap":12088134},{"date":"2023-10-20","current":-0.626313,"twenty":-5.001753,"median":-3.027649,"eighty":-1.540332,"marketCap":18333422},{"date":"2023-10-27","current":-0.496976,"twenty":-5.003376,"median":-3.028205,"eighty":-1.52385,"marketCap":14547496},{"date":"2023-11-03","current":-0.519585,"twenty":-5.003376,"median":-3.028205,"eighty":-1.506728,"marketCap":15209288},{"date":"2023-11-10","current":-0.547896,"twenty":-5.003376,"median":-3.028205,"eighty":-1.483899,"marketCap":16038018},{"date":"2023-11-17","current":-0.693345,"twenty":-5.003376,"median":-3.027649,"eighty":-1.472484,"marketCap":18214180},{"date":"2023-11-24","current":-0.636607,"twenty":-5.003376,"median":-3.027649,"eighty":-1.472484,"marketCap":16723658},{"date":"2023-12-01","current":-0.679388,"twenty":-5.003376,"median":-3.010907,"eighty":-1.454415,"marketCap":17847512},{"date":"2023-12-07","current":-0.6475,"twenty":-5.003376,"median":-3.010907,"eighty":-1.449655,"marketCap":17009838},{"date":"2023-12-15","current":-0.681998,"twenty":-5.005598,"median":-3.005336,"eighty":-1.43824,"marketCap":17916076},{"date":"2023-12-22","current":-0.76007,"twenty":-5.005598,"median":-3.005336,"eighty":-1.426825,"marketCap":19967034},{"date":"2023-12-29","current":-0.851078,"twenty":-5.00782,"median":-3.005443,"eighty":-1.418232,"marketCap":22357832},{"date":"2024-01-05","current":-1.157425,"twenty":-5.010041,"median":-3.00555,"eighty":-1.415411,"marketCap":30405553},{"date":"2024-01-12","current":-0.903555,"twenty":-5.010041,"median":-3.002764,"eighty":-1.401318,"marketCap":23736379},{"date":"2024-01-19","current":-0.701832,"twenty":-5.012263,"median":-2.975134,"eighty":-1.387165,"marketCap":18437125},{"date":"2024-01-26","current":-0.620049,"twenty":-5.010041,"median":-2.962755,"eighty":-1.381167,"marketCap":16288689},{"date":"2024-02-02","current":-0.65757,"twenty":-5.010041,"median":-2.948955,"eighty":-1.37209,"marketCap":17274363},{"date":"2024-02-09","current":-0.627044,"twenty":-5.010041,"median":-2.933352,"eighty":-1.369752,"marketCap":16472459},{"date":"2024-02-16","current":-0.635948,"twenty":-5.010041,"median":-2.903222,"eighty":-1.350843,"marketCap":16706348},{"date":"2024-02-23","current":-0.655026,"twenty":-5.010041,"median":-2.889463,"eighty":-1.324094,"marketCap":17207538},{"date":"2024-03-01","current":-0.800022,"twenty":-5.00782,"median":-2.876227,"eighty":-1.288444,"marketCap":21016585},{"date":"2024-03-08","current":-0.85217,"twenty":-5.00782,"median":-2.858329,"eighty":-1.269059,"marketCap":22386506},{"date":"2024-03-15","current":-0.681227,"twenty":-5.00782,"median":-2.850497,"eighty":-1.216797,"marketCap":17895839},{"date":"2024-03-22","current":-0.562177,"twenty":-5.00782,"median":-2.826724,"eighty":-1.187119,"marketCap":14768402},{"date":"2024-03-28","current":-0.41454,"twenty":-5.00782,"median":-2.819292,"eighty":-1.12548,"marketCap":12340438},{"date":"2024-04-05","current":-0.396581,"twenty":-5.010041,"median":-2.819868,"eighty":-1.084319,"marketCap":11805834},{"date":"2024-04-12","current":-0.356923,"twenty":-5.010041,"median":-2.817081,"eighty":-1.056695,"marketCap":10625251},{"date":"2024-04-19","current":-0.338479,"twenty":-5.010041,"median":-2.808468,"eighty":-0.951218,"marketCap":10076168},{"date":"2024-04-26","current":-0.322368,"twenty":-4.984446,"median":-2.774878,"eighty":-0.942537,"marketCap":9596584},{"date":"2024-05-03","current":-0.385357,"twenty":-4.974094,"median":-2.761076,"eighty":-0.928972,"marketCap":11471707},{"date":"2024-05-10","current":-0.357672,"twenty":-4.974094,"median":-2.747097,"eighty":-0.915662,"marketCap":10647526},{"date":"2024-05-17","current":-0.417701,"twenty":-4.974094,"median":-2.722422,"eighty":-0.898085,"marketCap":11204405},{"date":"2024-05-24","current":-0.427666,"twenty":-4.974094,"median":-2.703367,"eighty":-0.855223,"marketCap":11471707},{"date":"2024-05-31","current":-0.385314,"twenty":-4.974094,"median":-2.697971,"eighty":-0.828803,"marketCap":10335674},{"date":"2024-06-07","current":-0.384337,"twenty":-4.974094,"median":-2.690867,"eighty":-0.797102,"marketCap":10309450},{"date":"2024-06-14","current":-0.374858,"twenty":-4.974094,"median":-2.675203,"eighty":-0.790674,"marketCap":10055181},{"date":"2024-06-21","current":-0.325738,"twenty":-4.974094,"median":-2.668102,"eighty":-0.778182,"marketCap":8737606},{"date":"2024-06-28","current":-0.303333,"twenty":-4.974094,"median":-2.658563,"eighty":-0.774095,"marketCap":8136606},{"date":"2024-07-05","current":-0.312812,"twenty":-4.974094,"median":-2.656134,"eighty":-0.7557,"marketCap":8390875},{"date":"2024-07-12","current":-0.340388,"twenty":-4.974094,"median":-2.64511,"eighty":-0.713305,"marketCap":9130567},{"date":"2024-07-15","current":-0.374858,"twenty":-4.974094,"median":-2.64511,"eighty":-0.711355,"marketCap":10055181},{"date":"2024-08-02","current":-0.195615,"twenty":-4.986857,"median":-2.636896,"eighty":-0.701832,"marketCap":5247186},{"date":"2024-08-09","current":-0.189152,"twenty":-4.986857,"median":-2.625739,"eighty":-0.692211,"marketCap":5073821},{"date":"2024-08-16","current":-0.204821,"twenty":-4.986857,"median":-2.619908,"eighty":-0.672465,"marketCap":5154725},{"date":"2024-08-23","current":-0.510683,"twenty":-4.974094,"median":-2.60347,"eighty":-0.661386,"marketCap":12852365},{"date":"2024-08-30","current":-0.536006,"twenty":-4.974094,"median":-2.594501,"eighty":-0.65757,"marketCap":13489673},{"date":"2024-09-06","current":-0.525455,"twenty":-4.959273,"median":-2.58903,"eighty":-0.654434,"marketCap":13224128},{"date":"2024-09-13","current":-0.512793,"twenty":-4.925805,"median":-2.574402,"eighty":-0.651592,"marketCap":12905474},{"date":"2024-09-20","current":-0.278044,"twenty":-4.917787,"median":-2.562149,"eighty":-0.646935,"marketCap":6997536},{"date":"2024-09-27","current":-0.275784,"twenty":-4.862574,"median":-2.543279,"eighty":-0.644469,"marketCap":6940645},{"date":"2024-10-04","current":-0.278044,"twenty":-4.839659,"median":-2.530279,"eighty":-0.638873,"marketCap":6997536},{"date":"2024-10-11","current":-0.274653,"twenty":-4.839659,"median":-2.512967,"eighty":-0.635948,"marketCap":6912200},{"date":"2024-10-18","current":-0.266741,"twenty":-4.839659,"median":-2.497974,"eighty":-0.628952,"marketCap":6713083},{"date":"2024-10-25","current":-0.287086,"twenty":-4.837049,"median":-2.474207,"eighty":-0.62569,"marketCap":7225098},{"date":"2024-10-31","current":-0.287086,"twenty":-4.752061,"median":-2.460772,"eighty":-0.624124,"marketCap":7225098},{"date":"2024-11-08","current":-0.264481,"twenty":-4.713381,"median":-2.437821,"eighty":-0.621124,"marketCap":6656193},{"date":"2024-11-15","current":-0.291529,"twenty":-4.667079,"median":-2.424759,"eighty":-0.616561,"marketCap":8789588},{"date":"2024-11-22","current":-0.28177,"twenty":-4.667079,"median":-2.401436,"eighty":-0.611805,"marketCap":8495362},{"date":"2024-11-29","current":-0.275796,"twenty":-4.667079,"median":-2.387249,"eighty":-0.604465,"marketCap":8315249},{"date":"2024-12-06","current":-0.248913,"twenty":-4.667079,"median":-2.356043,"eighty":-0.59825,"marketCap":7504737},{"date":"2024-12-13","current":-0.244931,"twenty":-4.667079,"median":-2.338254,"eighty":-0.593495,"marketCap":7384661},{"date":"2024-12-20","current":-0.180213,"twenty":-4.667079,"median":-2.324837,"eighty":-0.589406,"marketCap":5433429},{"date":"2024-12-27","current":-0.176231,"twenty":-4.667079,"median":-2.310472,"eighty":-0.582084,"marketCap":5313354},{"date":"2025-01-03","current":-0.176231,"twenty":-4.667079,"median":-2.306223,"eighty":-0.575062,"marketCap":5313354},{"date":"2025-01-10","current":-0.177226,"twenty":-4.669263,"median":-2.294406,"eighty":-0.570362,"marketCap":5343373},{"date":"2025-01-17","current":-0.173244,"twenty":-4.669263,"median":-2.283926,"eighty":-0.566314,"marketCap":5223297},{"date":"2025-01-24","current":-0.175235,"twenty":-4.669263,"median":-2.265174,"eighty":-0.56442,"marketCap":5283335},{"date":"2025-01-31","current":-0.153331,"twenty":-4.669263,"median":-2.248133,"eighty":-0.562387,"marketCap":4622918},{"date":"2025-02-07","current":-0.083675,"twenty":-4.669263,"median":-2.219202,"eighty":-0.56007,"marketCap":2522792},{"date":"2025-02-14","current":-0.126448,"twenty":-4.669263,"median":-2.168808,"eighty":-0.542573,"marketCap":3812406},{"date":"2025-02-21","current":-0.139391,"twenty":-4.669263,"median":-2.136557,"eighty":-0.53664,"marketCap":4202653},{"date":"2025-02-28","current":-0.126448,"twenty":-4.669263,"median":-2.07519,"eighty":-0.529915,"marketCap":3812406},{"date":"2025-03-07","current":-0.109522,"twenty":-4.671446,"median":-2.030693,"eighty":-0.519911,"marketCap":3302084},{"date":"2025-03-14","current":-0.115496,"twenty":-4.671446,"median":-2.016972,"eighty":-0.508863,"marketCap":3482198},{"date":"2025-03-21","current":-0.108526,"twenty":-4.671446,"median":-2.016972,"eighty":-0.50182,"marketCap":3272065},{"date":"2025-03-28","current":-0.675482,"twenty":-4.671446,"median":-1.96597,"eighty":-0.498418,"marketCap":14700518},{"date":"2025-04-04","current":-0.558849,"twenty":-4.671446,"median":-1.948368,"eighty":-0.498418,"marketCap":12162229},{"date":"2025-04-11","current":-0.470329,"twenty":-4.638525,"median":-1.875116,"eighty":-0.493187,"marketCap":10235761},{"date":"2025-04-17","current":-0.591208,"twenty":-4.595196,"median":-1.701084,"eighty":-0.493187,"marketCap":12866453},{"date":"2025-04-25","current":-0.714081,"twenty":-4.566151,"median":-1.609459,"eighty":-0.49288,"marketCap":15540548},{"date":"2025-05-02","current":-0.649749,"twenty":-4.553113,"median":-1.577904,"eighty":-0.49288,"marketCap":14140498},{"date":"2025-05-09","current":-0.649749,"twenty":-4.553113,"median":-1.539373,"eighty":-0.49288,"marketCap":14140498},{"date":"2025-05-16","current":-0.549617,"twenty":-4.475418,"median":-1.506728,"eighty":-0.49288,"marketCap":12767050},{"date":"2025-05-23","current":-0.566372,"twenty":-4.368028,"median":-1.483899,"eighty":-0.49288,"marketCap":13156264},{"date":"2025-05-30","current":-0.547146,"twenty":-4.296194,"median":-1.483784,"eighty":-0.49288,"marketCap":12709648},{"date":"2025-06-06","current":-0.419707,"twenty":-4.228663,"median":-1.472484,"eighty":-0.489644,"marketCap":9749383},{"date":"2025-06-13","current":-0.406571,"twenty":-4.002393,"median":-1.461069,"eighty":-0.464266,"marketCap":9444229},{"date":"2025-06-20","current":-0.354571,"twenty":-3.940538,"median":-1.449655,"eighty":-0.442788,"marketCap":8236329},{"date":"2025-06-27","current":-0.195835,"twenty":-3.816828,"median":-1.43824,"eighty":-0.430985,"marketCap":4549053},{"date":"2025-07-03","current":-0.352742,"twenty":-3.765888,"median":-1.426825,"eighty":-0.427024,"marketCap":8193836},{"date":"2025-07-11","current":-0.554012,"twenty":-3.725864,"median":-1.415411,"eighty":-0.422336,"marketCap":12869143},{"date":"2025-07-18","current":-1.086632,"twenty":-3.615274,"median":-1.409703,"eighty":-0.422336,"marketCap":25241381},{"date":"2025-07-25","current":-0.828369,"twenty":-3.530431,"median":-1.392582,"eighty":-0.422336,"marketCap":19242173},{"date":"2025-08-01","current":-0.816665,"twenty":-3.455744,"median":-1.381167,"eighty":-0.422336,"marketCap":18970306},{"date":"2025-08-08","current":-0.880906,"twenty":-3.401293,"median":-1.37209,"eighty":-0.422336,"marketCap":20462556},{"date":"2025-08-15","current":-0.73896,"twenty":-3.383274,"median":-1.369752,"eighty":-0.422336,"marketCap":19619379},{"date":"2025-08-22","current":-0.680669,"twenty":-3.383274,"median":-1.35734,"eighty":-0.422336,"marketCap":18071756},{"date":"2025-08-29","current":-0.448418,"twenty":-3.383274,"median":-1.324094,"eighty":-0.422336,"marketCap":11905492},{"date":"2025-09-05","current":-0.432334,"twenty":-3.383842,"median":-1.28985,"eighty":-0.421853,"marketCap":11478457},{"date":"2025-09-12","current":-0.520301,"twenty":-3.383274,"median":-1.271378,"eighty":-0.422336,"marketCap":13813999},{"date":"2025-09-19","current":-0.570117,"twenty":-3.383274,"median":-1.224623,"eighty":-0.422336,"marketCap":15136616},{"date":"2025-09-26","current":-0.819756,"twenty":-3.383274,"median":-1.190488,"eighty":-0.422336,"marketCap":21764523},{"date":"2025-10-03","current":-0.932177,"twenty":-3.383274,"median":-1.124338,"eighty":-0.422336,"marketCap":24749288},{"date":"2025-10-10","current":-0.962193,"twenty":-3.383274,"median":-1.08551,"eighty":-0.422336,"marketCap":25546215},{"date":"2025-10-17","current":-0.899364,"twenty":-3.383274,"median":-1.070018,"eighty":-0.422336,"marketCap":23878113},{"date":"2025-10-24","current":-0.914279,"twenty":-3.383274,"median":-1.021953,"eighty":-0.422336,"marketCap":24274101},{"date":"2025-10-31","current":-0.842315,"twenty":-3.383274,"median":-0.97515,"eighty":-0.422336,"marketCap":22363456},{"date":"2025-11-07","current":-0.851077,"twenty":-3.383274,"median":-0.95082,"eighty":-0.422336,"marketCap":22596099},{"date":"2025-11-14","current":-0.84623,"twenty":-3.383274,"median":-0.946546,"eighty":-0.422336,"marketCap":22467403},{"date":"2025-11-21","current":-0.417396,"twenty":-3.383274,"median":-0.935191,"eighty":-0.420044,"marketCap":21458765},{"date":"2025-11-28","current":-0.270045,"twenty":-3.383274,"median":-0.928079,"eighty":-0.418029,"marketCap":13883286},{"date":"2025-12-05","current":-0.305397,"twenty":-3.380203,"median":-0.924038,"eighty":-0.414937,"marketCap":15700790},{"date":"2025-12-12","current":-0.198053,"twenty":-3.380203,"median":-0.91642,"eighty":-0.409901,"marketCap":10182095},{"date":"2025-12-19","current":-0.229509,"twenty":-3.380203,"median":-0.912974,"eighty":-0.40792,"marketCap":11799264},{"date":"2025-12-26","current":-0.233703,"twenty":-3.380203,"median":-0.905143,"eighty":-0.406728,"marketCap":12014917},{"date":"2026-01-02","current":-0.198348,"twenty":-3.380203,"median":-0.900389,"eighty":-0.403557,"marketCap":10197275},{"date":"2026-01-09","current":-0.246166,"twenty":-3.380203,"median":-0.893492,"eighty":-0.397276,"marketCap":12655631},{"date":"2026-01-16","current":-0.255749,"twenty":-3.358773,"median":-0.88622,"eighty":-0.39284,"marketCap":13148307},{"date":"2026-01-23","current":-0.285696,"twenty":-3.329922,"median":-0.873415,"eighty":-0.38937,"marketCap":14687922},{"date":"2026-01-30","current":-0.256348,"twenty":-3.272466,"median":-0.859078,"eighty":-0.385323,"marketCap":13179100},{"date":"2026-02-06","current":-0.234187,"twenty":-3.237941,"median":-0.851624,"eighty":-0.378965,"marketCap":12039785},{"date":"2026-02-13","current":-0.252515,"twenty":-3.216194,"median":-0.835718,"eighty":-0.37563,"marketCap":12982029},{"date":"2026-02-20","current":-0.160517,"twenty":-3.161891,"median":-0.815225,"eighty":-0.372789,"marketCap":8252333},{"date":"2026-02-27","current":-0.144345,"twenty":-3.085468,"median":-0.80193,"eighty":-0.363438,"marketCap":7420941},{"date":"2026-03-06","current":-0.214938,"twenty":-2.966348,"median":-0.79344,"eighty":-0.354778,"marketCap":11050166},{"date":"2026-03-13","current":-0.196706,"twenty":-2.930473,"median":-0.778317,"eighty":-0.348393,"marketCap":10112875},{"date":"2026-03-20","current":-0.302807,"twenty":-2.851104,"median":-0.769702,"eighty":-0.340905,"marketCap":10162206},{"date":"2026-03-27","current":-0.386392,"twenty":-2.76529,"median":-0.751228,"eighty":-0.338688,"marketCap":12967330},{"date":"2026-04-02","current":-0.354591,"twenty":-2.747097,"median":-0.737819,"eighty":-0.338688,"marketCap":11900060},{"date":"2026-04-10","current":-0.405474,"twenty":-2.714071,"median":-0.713216,"eighty":-0.338688,"marketCap":13607692},{"date":"2026-04-17","current":-0.381622,"twenty":-2.689837,"median":-0.700688,"eighty":-0.338688,"marketCap":12807240},{"date":"2026-04-24","current":-0.403883,"twenty":-2.656134,"median":-0.693053,"eighty":-0.338688,"marketCap":13554329},{"date":"2026-05-01","current":-0.407064,"twenty":-2.641896,"median":-0.687458,"eighty":-0.338688,"marketCap":13661056},{"date":"2026-05-08","current":-0.395933,"twenty":-2.636896,"median":-0.680948,"eighty":-0.338688,"marketCap":13287511},{"date":"2026-05-15","current":-0.34982,"twenty":-2.616936,"median":-0.675482,"eighty":-0.338688,"marketCap":11739970},{"date":"2026-05-22","current":-0.314903,"twenty":-2.56517,"median":-0.669282,"eighty":-0.325544,"marketCap":12753876},{"date":"2026-05-29","current":-0.361018,"twenty":-2.543279,"median":-0.662616,"eighty":-0.322368,"marketCap":14621599},{"date":"2026-06-05","current":-0.330714,"twenty":-2.510592,"median":-0.658817,"eighty":-0.322456,"marketCap":13394238},{"date":"2026-06-12","current":-0.355748,"twenty":-2.473318,"median":-0.656622,"eighty":-0.321146,"marketCap":14408145},{"date":"2026-06-18","current":-0.368924,"twenty":-2.435977,"median":-0.65473,"eighty":-0.321146,"marketCap":14941780},{"date":"2026-06-26","current":-0.393958,"twenty":-2.387249,"median":-0.652263,"eighty":-0.320994,"marketCap":15955686},{"date":"2026-07-02","current":-0.35443,"twenty":-2.373437,"median":-0.649749,"eighty":-0.320994,"marketCap":14354781},{"date":"2026-07-10","current":-0.321491,"twenty":-2.34044,"median":-0.647474,"eighty":-0.317538,"marketCap":13020694},{"date":"2026-07-17","current":-0.285916,"twenty":-2.310472,"median":-0.645105,"eighty":-0.314903,"marketCap":11579879},{"date":"2026-07-24","current":-0.274058,"twenty":-2.293632,"median":-0.641035,"eighty":-0.309632,"marketCap":11099608},{"date":"2026-07-31","current":-0.134394,"twenty":-2.265547,"median":-0.637057,"eighty":-0.30519,"marketCap":5443077},{"date":"2026-08-07","current":-0.050727,"twenty":-2.217051,"median":-0.635194,"eighty":-0.302807,"marketCap":2054494},{"date":"2026-08-14","current":-0.075274,"twenty":-2.157106,"median":-0.627998,"eighty":-0.299882,"marketCap":3048656},{"date":"2026-08-21","current":-0.37931,"twenty":-2.07519,"median":-0.625788,"eighty":-0.295337,"marketCap":11503340}],"updateTime":1787527623433},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MBRX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635728711","title":"Moleculin Biotech Q1 FY26 net loss widens to $12.85 million; operating loss widens to $7.87 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635728711","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635728711?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:02","pubTimestamp":1778788950,"startTime":"0","endTime":"0","summary":"Moleculin Biotech posted a net loss of $12.85 million for the quarter ended March 31, 2026, widening from $5.9 million a year earlier.Operating loss widened to $7.87 million as research and development expense rose to $5.38 million, while general and administrative costs were $2.49 million.Cash used in operating activities increased to $6.11 million, while net cash provided by financing activities slipped to $7.61 million.Phase 2B/3 MIRACLE trial first unblinding remains on track to occur prior to June 30, 2026; preliminary blinded data for first 45 subjects showed CRc exceeding 40% with CR about 30%.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief vi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL2GFXS4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635728565","title":"Buy Rating Reiterated on Moleculin Biotech as MIRACLE Trial Progress Supports Unchanged $10 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2635728565","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635728565?lang=en_us&edition=fundamental","pubTime":"2026-05-15 03:25","pubTimestamp":1778786716,"startTime":"0","endTime":"0","summary":"Analyst Jason McCarthy of Maxim Group maintained a Buy rating on Moleculin Biotech, retaining the price target of $10.00. Jason McCarthy has given ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-on-moleculin-biotech-as-miracle-trial-progress-supports-unchanged-10-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-on-moleculin-biotech-as-miracle-trial-progress-supports-unchanged-10-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","XBI","MBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635731244","title":"Nano-Cap Moleculin Biotech Approaches Key Leukemia Trial Data Unblinding","url":"https://stock-news.laohu8.com/highlight/detail?id=2635731244","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635731244?lang=en_us&edition=fundamental","pubTime":"2026-05-14 00:41","pubTimestamp":1778690460,"startTime":"0","endTime":"0","summary":"Moleculin Biotech nears first MIRACLE trial data unblinding as Annamycin shows higher remission rates in relapsed AML patients.","market":"nz","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/05/13/Acute-Myeloid-Leukemia-Is-A-Subtype-Of-B_0.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/05/13/Acute-Myeloid-Leukemia-Is-A-Subtype-Of-B_0.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/health-care/26/05/52534429/nano-cap-moleculin-biotech-approaches-key-leukemia-trial-data-unblinding","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/05/52534429/nano-cap-moleculin-biotech-approaches-key-leukemia-trial-data-unblinding","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["MBRX","BK4581","BK4585","BK4139","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635339687","title":"Moleculin Biotech expects first unblinding of MIRACLE trial data by June 30","url":"https://stock-news.laohu8.com/highlight/detail?id=2635339687","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635339687?lang=en_us&edition=fundamental","pubTime":"2026-05-13 22:09","pubTimestamp":1778681393,"startTime":"0","endTime":"0","summary":"Moleculin Biotech (MBRX) announced it is approaching the first unblinding of data from its pivotal Phase 2B/3 “MIRACLE” trial evaluating Annamycin ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moleculin-biotech-expects-first-unblinding-of-miracle-trial-data-by-june-30-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moleculin-biotech-expects-first-unblinding-of-miracle-trial-data-by-june-30-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4139","XBI","BK4581","BK4588","MBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635378441","title":"BRIEF-Moleculin Biotech Inc - To Unblind Miracle Trial Data Before June 30, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2635378441","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635378441?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:12","pubTimestamp":1778674376,"startTime":"0","endTime":"0","summary":"BRIEF-Moleculin Biotech Inc - To Unblind Miracle Trial Data Before June 30, 2026 - SEC FilingMay 13  - Moleculin Biotech Inc MBRX.O:MOLECULIN BIOTECH INC - TO UNBLIND MIRACLE TRIAL DATA BEFORE JUNE 30, 2026 - SEC FILINGMOLECULIN BIOTECH INC - MIRACLE TRIAL ON TRACK TO COMPLETE PART A RECRUITMENT IN Q3 2026 - SEC FILINGFurther company coverage: MBRX.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nFWN41Q11B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635535784","title":"Moleculin Biotech Inc - Miracle Trial on Track to Complete Part a Recruitment in Q3 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2635535784","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635535784?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:03","pubTimestamp":1778673787,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nFWN41Q11B:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635843167","title":"Moleculin nears MIRACLE trial unblinding for Annamycin in relapsed AML by June 30","url":"https://stock-news.laohu8.com/highlight/detail?id=2635843167","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635843167?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:02","pubTimestamp":1778673731,"startTime":"0","endTime":"0","summary":"Moleculin Biotech flagged late Q2 2026 unblinding for first 45 patients in pivotal MIRACLE trial testing Annamycin with cytarabine in relapsed or refractory acute myeloid leukemia, with results expected before June 30, 2026.Blinded interim data showed remission outcomes tracking well above historical experience for cytarabine alone, signaling potential added benefit without disclosing arm-level performance.Safety readout remained consistent with no cardiotoxicity observed to date, supporting continued development focus for Annamycin in this setting.Enrollment continued toward 90 patients for Part A in Q3 2026, keeping timeline intact for a second unblinding later in 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL2XbzCP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635242898","title":"Moleculin announces publication on cardiac safety profiloe of annamycin","url":"https://stock-news.laohu8.com/highlight/detail?id=2635242898","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635242898?lang=en_us&edition=fundamental","pubTime":"2026-05-13 03:17","pubTimestamp":1778613450,"startTime":"0","endTime":"0","summary":"Moleculin Biotech (MBRX) announced the publication of an abstract at the European Hematology Association 2026 Congress highlighting the cardiac saf...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moleculin-announces-publication-on-cardiac-safety-profiloe-of-annamycin-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moleculin-announces-publication-on-cardiac-safety-profiloe-of-annamycin-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","EPV","BK4581","XBI","BK4585","BK4139","MBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634127872","title":"Moleculin says Cleveland Clinic review finds no significant Annamycin cardiotoxicity in R/R AML","url":"https://stock-news.laohu8.com/highlight/detail?id=2634127872","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634127872?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:32","pubTimestamp":1778592738,"startTime":"0","endTime":"0","summary":"Moleculin Biotech flagged new pooled cardiac safety findings for its anthracycline Annamycin in relapsed or refractory acute myeloid leukemia, with results set for presentation at European Hematology Association 2026 Congress.Independent Cleveland Clinic review of multiple completed trials found no clinically meaningful treatment-related heart toxicity, including in patients treated beyond conventional lifetime exposure limits for standard anthracyclines.Analysis showed cardiac function remained stable over treatment, supporting plans to position Annamycin for heavily pretreated patients who often cannot receive further anthracycline therapy due to cardiotoxicity risk.Company framed safety profile as a potential differentiator that could expand use in AML salvage settings where current options have limited benefit.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL7GLfhY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014039.USD","BK4585","LU2210149790.SGD","BK4139","IE00BN0W2V16.EUR","BK4112","BK4588","IE00B64PRP62.GBP","SG9999014013.SGD","MBRX","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2095319765.USD","NDAQ","SG9999014005.SGD","IE00BGHQF748.EUR","LU2210150020.SGD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633468923","title":"Moleculin Biotech issued liposomal Annamycin patent in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2633468923","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633468923?lang=en_us&edition=fundamental","pubTime":"2026-05-08 23:28","pubTimestamp":1778254134,"startTime":"0","endTime":"0","summary":"Moleculin Biotech (MBRX) announced a significant advancement in its intellectual property portfolio with the issuance of a Hong Kong patent coverin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moleculin-biotech-issued-liposomal-annamycin-patent-in-hong-kong-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moleculin-biotech-issued-liposomal-annamycin-patent-in-hong-kong-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4581","MBRX","XBI","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633953459","title":"Moleculin Biotech secures Hong Kong patent for liposomal Annamycin reconstitution method","url":"https://stock-news.laohu8.com/highlight/detail?id=2633953459","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633953459?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:45","pubTimestamp":1778244339,"startTime":"0","endTime":"0","summary":"Moleculin Biotech won a Hong Kong patent covering its method of reconstituting liposomal Annamycin, extending protection through June 25, 2040.Patent, No. 40073244, is jointly owned with University of Texas System.Move expands intellectual property coverage for lead cancer drug candidate ahead of expected first Phase 3 data release later this quarter.Annamycin is being developed for relapsed or refractory acute myeloid leukemia, with a separate program in soft tissue sarcoma lung metastases.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL47ZCkx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BN0W2W23.USD","BK4112","SG9999014039.USD","IE00BN0W2V16.EUR","BK4139","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","SG9999014005.SGD","LU2095319765.USD","SG9999014013.SGD","LU2210150020.SGD","SG9999014021.USD","IE00BKPKM429.USD","MBRX","IE00BGHQF748.EUR","LU0314104364.USD","NDAQ","BK4585","BK4588","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633459274","title":"Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin","url":"https://stock-news.laohu8.com/highlight/detail?id=2633459274","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633459274?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:45","pubTimestamp":1778244300,"startTime":"0","endTime":"0","summary":"Solid Intellectual Property Protection Across Four Continents Ahead of Pending Phase 3 Data Release HOUSTON, May  08, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/08/3291067/0/en/Moleculin-Biotech-Secures-Strategic-Additional-Patent-Strengthening-Global-Positioning-of-Annamycin.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX","BK4581","BK4585","BK4139","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629556831","title":"Moleculin says Annamycin extends survival 60% in pancreatic cancer preclinical models","url":"https://stock-news.laohu8.com/highlight/detail?id=2629556831","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629556831?lang=en_us&edition=fundamental","pubTime":"2026-04-23 20:25","pubTimestamp":1776947121,"startTime":"0","endTime":"0","summary":"Moleculin Biotech highlighted new preclinical pancreatic cancer data presented at AACR 2026 for liposomal Annamycin.Studies showed the drug reduced tumor growth across multiple models, supporting a potential expansion into pancreatic ductal adenocarcinoma.A metastatic model showed a clear survival benefit versus control, reinforcing potential relevance in aggressive disease.Drug distribution work indicated higher tumor and pancreatic tissue accumulation than doxorubicin, supporting a differentiated efficacy profile.Company is running its pivotal Phase 2B/3 MIRACLE trial in relapsed or refractory acute myeloid leukemia testing Annamycin with cytarabine.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDLblwQmh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","IE00BKPKM429.USD","SG9999014039.USD","LU2095319765.USD","IE00BN0W2W23.USD","SG9999014005.SGD","IE00B64PRP62.GBP","MBRX","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","LU0314104364.USD","BK4585","LU2210150020.SGD","SG9999014021.USD","SG9999014013.SGD","NDAQ","IE00BN0W2T93.GBP","BK4112","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629031846","title":"Moleculin to present annamycin cardiac safety pooled analysis at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2629031846","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629031846?lang=en_us&edition=fundamental","pubTime":"2026-04-21 20:36","pubTimestamp":1776774981,"startTime":"0","endTime":"0","summary":"Moleculin Biotech disclosed acceptance of an abstract on its lead drug candidate annamycin for poster presentation at 2026 ASCO Annual Meeting.Data will be presented May 30, 2026, in Chicago.Poster reports pooled analysis indicating annamycin maintained a favorable cardiac safety profile in patients with high cumulative anthracycline exposure.Update supports positioning annamycin as a differentiated anthracycline candidate for patients where cardiotoxicity risk can limit use of standard therapies.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL5BgpD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","NDAQ","BK4585","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU0314104364.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","MBRX","BK4112","LU2095319765.USD","BK4139","SG9999014039.USD","SG9999014021.USD","BK4588","SG9999014013.SGD","SG9999014005.SGD","IE00B3QW5Z07.USD","LU2210150020.SGD","LU2210149790.SGD","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627236156","title":"Moleculin Biotech Stockholders Approve Warrant Share Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=2627236156","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627236156?lang=en_us&edition=fundamental","pubTime":"2026-04-15 23:59","pubTimestamp":1776268761,"startTime":"0","endTime":"0","summary":"Moleculin Biotech ( ($MBRX) ) has shared an update. At a special meeting of stockholders held on April 15, 2026, Moleculin Biotech, Inc. obtained a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/moleculin-biotech-stockholders-approve-warrant-share-issuance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/moleculin-biotech-stockholders-approve-warrant-share-issuance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MBRX","XBI","BK4581","BK4588","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625573957","title":"Moleculin CEO highlights Annamycin’s non-cardiotoxic profile in CEO Corner interview","url":"https://stock-news.laohu8.com/highlight/detail?id=2625573957","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625573957?lang=en_us&edition=fundamental","pubTime":"2026-04-08 00:52","pubTimestamp":1775580738,"startTime":"0","endTime":"0","summary":"Moleculin management released a CEO Corner segment featuring CEO Walter Klemp highlighting Annamycin safety profile.Klemp emphasized Annamycin was designed to avoid cardiotoxicity seen with traditional anthracyclines such as doxorubicin.Segment positioned non-cardiotoxic profile as potential differentiator for relapsed or refractory AML patients, including those with prior anthracycline exposure or cardiac risk factors.Klemp linked safety profile to potential regulatory and commercial advantages as Moleculin advances its pivotal Phase 3 MIRACLE trial of AnnAraC in relapsed or refractory AML.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDLl7Ry2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00BN0W2W23.USD","BK4585","LU2210150020.SGD","BK4588","LU2210149790.SGD","BK4112","NDAQ","BK4139","SG9999014005.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","MBRX","LU0314104364.USD","LU2095319765.USD","SG9999014013.SGD","SG9999014021.USD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624768853","title":"Moleculin Biotech management to meet with Maxim","url":"https://stock-news.laohu8.com/highlight/detail?id=2624768853","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624768853?lang=en_us&edition=fundamental","pubTime":"2026-04-02 23:10","pubTimestamp":1775142634,"startTime":"0","endTime":"0","summary":"Meetings to be held April 8-9 hosted by Maxim. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moleculin-biotech-management-to-meet-with-maxim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moleculin-biotech-management-to-meet-with-maxim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","MBRX","BK4139","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622808630","title":"Moleculin Biotech files to sell 6.37M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2622808630","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622808630?lang=en_us&edition=fundamental","pubTime":"2026-03-28 04:07","pubTimestamp":1774642051,"startTime":"0","endTime":"0","summary":"16:02 EDT Moleculin Biotech (MBRX) files to sell 6.37M shares of common stock for holders Published first on TheFly – the ultimate source for real-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moleculin-biotech-files-to-sell-6-37m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moleculin-biotech-files-to-sell-6-37m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","MBRX","BK4581","BK4139","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621093842","title":"Moleculin Biotech Price Target Maintained With a $22.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2621093842","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621093842?lang=en_us&edition=fundamental","pubTime":"2026-03-24 22:10","pubTimestamp":1774361400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MBRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 24, 2026 10:10 ET (14:10 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","MBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621705512","title":"Moleculin enrolls 45th patient in MIRACLE AnnAraC trial for relapsed or refractory AML","url":"https://stock-news.laohu8.com/highlight/detail?id=2621705512","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621705512?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:32","pubTimestamp":1774269179,"startTime":"0","endTime":"0","summary":"Moleculin reported enrollment of the 45th subject in its global adaptive Phase 2B/3 MIRACLE trial evaluating Annamycin plus cytarabine versus cytarabine plus placebo in adults with relapsed or refractory acute myeloid leukemia.The company said interim unblinding of data after 45 subjects complete treatment is planned for mid-2026, with an expected dataset of about 30 patients in the Annamycin combination arms and 15 in the control arm.Preliminary blinded results were previously presented as a 40% composite complete remission rate among the first 30 enrolled patients.Enrollment is continuing toward 90 total subjects, with Part A expected to conclude in Q3 2026 followed by complete unblinding of Part A.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or l","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL19Dp90:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":70,"code":"91000000","status":"200"}]}}